Treatment of acyclovir-resistant varicella-zoster virus keratitis with amenamevir in an immunocompromised patient
Journal of Antimicrobial Chemotherapy · 04.08.2026 · 81 (9)
DOI: 10.1093/jac/dkag275 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 06.08.2026. Verfasst von Antoine Portais und 2 weiteren Autor:innen. Beteiligte Einrichtung: Infectious and Tropical Diseases Unit, Centre Hospitalier de Polynésie Française, Pirae, Tahiti, French Polynesia, France. Die Arbeit nennt 14 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Infectious and Tropical Diseases Unit, Centre Hospitalier de Polynésie Française, Pirae, Tahiti, French Polynesia, France.
- Virology Unit, Centre Hospitalier de Polynésie Française, Tahiti, French Polynesia, France.
- National Reference Centre for Herperviruses (Associated Laboratory), AP-HP. Sorbonne Université, Pitié-Salpêtrière University Hospital, Virology Department, and Sorbonne Université, INSERM, Sorbonne Public Health Instit…
ORCID-Profile: Antoine Portais
Zitieren
APA
Portais, A., Lastere, S., & Boutolleau, D. (2026). Treatment of acyclovir-resistant varicella-zoster virus keratitis with amenamevir in an immunocompromised patient. Journal of Antimicrobial Chemotherapy, 81(9). https://doi.org/10.1093/jac/dkag275
Vancouver
Portais A, Lastere S, Boutolleau D. Treatment of acyclovir-resistant varicella-zoster virus keratitis with amenamevir in an immunocompromised patient. Journal of Antimicrobial Chemotherapy. 2026;81(9). doi:10.1093/jac/dkag275
BibTeX
@article{Portais2026,
author = {Portais, Antoine and Lastere, Stéphane and Boutolleau, David},
title = {Treatment of acyclovir-resistant varicella-zoster virus keratitis with amenamevir in an immunocompromised patient},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2026},
volume = {81},
number = {9},
doi = {10.1093/jac/dkag275}
}
EUVIMED